McKesson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade McKesson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. 

CEO
Brian Scott Tyler
CEOBrian Scott Tyler
Employees
43,000
Employees43,000
Headquarters
Irving, Texas
HeadquartersIrving, Texas
Founded
1833
Founded1833
Employees
43,000
Employees43,000

MCK Key Statistics

Market cap
105.54B
Market cap105.54B
Price-Earnings ratio
23.38
Price-Earnings ratio23.38
Dividend yield
0.38%
Dividend yield0.38%
Average volume
901.92K
Average volume901.92K
High today
$905.65
High today$905.65
Low today
$869.37
Low today$869.37
Open price
$872.33
Open price$872.33
Volume
877.93K
Volume877.93K
52 Week high
$999.00
52 Week high$999.00
52 Week low
$673.38
52 Week low$673.38

Stock Snapshot

With a market cap of 105.54B, McKesson(MCK) trades at $905.09. The stock has a price-to-earnings ratio of 23.38 and currently yields dividends of 0.38%.

During the trading session on 2026-08-26, McKesson(MCK) shares reached a daily high of $905.65 and a low of $869.37. At a current price of $905.09, the stock is +4.1% higher than the low and still -0.1% under the high.

Trading volume for McKesson(MCK) stock has reached 877.93K, versus its average volume of 901.92K.

The stock's 52-week range extends from a low of $673.38 to a high of $999.00.

The stock's 52-week range extends from a low of $673.38 to a high of $999.00.

MCK News

Investing.com 8h
Why is McKesson stock rallying today? - Investing.com

...

Why is McKesson stock rallying today? - Investing.com
TipRanks 10h
Morgan Stanley views Precision Medicine as logical addition to McKesson platform

Commenting on McKesson’s (MCK) acquisition of Precision Medicine Group for $2.25B, Morgan Stanley says the company’s CRO acquisition was a long time coming. Pre...

Nasdaq 12h
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now

McKesson’s MCK prospects are being driven by robust growth in specialty distribution, oncology services and biopharma solutions. Earnings are also improving on...

Here's Why You Should Retain McKesson Stock in Your Portfolio for Now

Analyst ratings

75%

of 20 ratings
Buy
75%
Hold
25%
Sell
0%

More MCK News

Nasdaq 16h
McKesson To Acquire Precision Medicine Group For $2.25 Bln

(RTTNews) - Tuesday, McKesson Corp. (MCK) announced an agreement to acquire Precision Medicine Group, LLC, a global provider of clinical research and biopharma...

McKesson To Acquire Precision Medicine Group For $2.25 Bln
TipRanks 4d
McKesson Earnings Call Signals Robust Growth Ahead

McKesson Corporation ((MCK)) has held its Q1 earnings call. Read on for the main highlights of the call. Summer Sale - Claim 70% Off TipRanks Unlock powerful in...

Simply Wall St 5d
McKesson Stock Still Looks Cheap Following Its 338% Five Year Run

McKesson stock has delivered a very strong 5 year return, yet the current share price of US$853.71 still screens as undervalued on both an intrinsic value estim...

McKesson Stock Still Looks Cheap Following Its 338% Five Year Run
Simply Wall St 6d
McKesson Could Be 11% Undervalued After Earnings And Buybacks

McKesson (MCK) reported first quarter 2026 earnings on August 5, with sales of US$105.38b compared with US$97.83b a year earlier, while net income and earnings...

McKesson Could Be 11% Undervalued After Earnings And Buybacks
Nasdaq 7d
September 2027 Options Now Available For McKesson

Investors in McKesson Corp (Symbol: MCK) saw new options become available today, for the September 2027 expiration. One of the key inputs that goes into the pri...

September 2027 Options Now Available For McKesson
Nasdaq 7d
Trumpflation" Is Real -- and Getting Worse. Here Are 2 Stocks That Turn Rising Prices Into Rising Profits.

Key Points This pair of stocks offer inflation exposure but they don't need rising prices to succeed. McKesson can benefit when certain pharmaceutical prices...

Trumpflation" Is Real -- and Getting Worse. Here Are 2 Stocks That Turn Rising Prices Into Rising Profits.
TipRanks 7d
McKesson price target raised to $1,000 from $925 at Barclays

Barclays analyst Glen Santangelo raised the firm’s price target on McKesson (MCK) to $1,000 from $925 and keeps an Overweight rating on the shares. The firm upd...

People also own

Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.